Dondi, F.; Miceli, A.; Rovera, G.; Feudo, V.; Battisti, C.; Rondini, M.; Marongiu, A.; Mura, A.; Camedda, R.; De Feo, M.S.;
et al. Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand? Bioengineering 2024, 11, 714.
https://doi.org/10.3390/bioengineering11070714
AMA Style
Dondi F, Miceli A, Rovera G, Feudo V, Battisti C, Rondini M, Marongiu A, Mura A, Camedda R, De Feo MS,
et al. Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand? Bioengineering. 2024; 11(7):714.
https://doi.org/10.3390/bioengineering11070714
Chicago/Turabian Style
Dondi, Francesco, Alberto Miceli, Guido Rovera, Vanessa Feudo, Claudia Battisti, Maria Rondini, Andrea Marongiu, Antonio Mura, Riccardo Camedda, Maria Silvia De Feo,
and et al. 2024. "Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand?" Bioengineering 11, no. 7: 714.
https://doi.org/10.3390/bioengineering11070714
APA Style
Dondi, F., Miceli, A., Rovera, G., Feudo, V., Battisti, C., Rondini, M., Marongiu, A., Mura, A., Camedda, R., De Feo, M. S., Conte, M., Gorica, J., Ferrari, C., Nappi, A. G., & Santo, G.
(2024). Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand? Bioengineering, 11(7), 714.
https://doi.org/10.3390/bioengineering11070714
